CompletedPhase 2NCT03862950

A Trial of Metformin in Individuals With Fragile X Syndrome (Met)

Studying Fragile X syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Alberta
Principal Investigator
Francois Bolduc, MD
University of Alberta
Intervention
Placebo Medication(drug)
Enrollment
125 enrolled
Eligibility
6-35 years · All sexes
Timeline
20192025

Study locations (2)

Collaborators

St. Justine's Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03862950 on ClinicalTrials.gov

Other trials for Fragile X syndrome

Additional recruiting or active studies for the same condition.

See all trials for Fragile X syndrome

← Back to all trials